Clarivate Plc SEC Filings

A shareholder of Clarivate (CLVT) has filed a Form 144 notice to sell up to 309,902 shares of common stock. The proposed sale, to be executed through Morgan Stanley Smith Barney LLC on the NYSE, has an aggregate market value of $1,160,273.09. The filing lists an approximate sale date of 12/01/2025. The shares come from restricted stock acquired from the issuer on 03/01/2025 and 05/01/2025 in amounts of 37,793 and 272,109 shares, respectively, and are being sold against a total of 661,435,069 shares outstanding.

Clarivate plc insider reports routine share withholding for taxes. A senior officer of Clarivate plc (CLVT), serving as Senior VP, Finance and Chief Accounting Officer, reported a Form 4 transaction dated 11/15/2025. The filing shows that 50,520 ordinary shares were disposed of at a price of $3.46 per share, identified as shares withheld to cover taxes due upon the vesting of restricted share units. After this tax-related withholding, the reporting person directly held 494,171 ordinary shares of Clarivate.

Clarivate PLC (CLVT) director reported an open‑market purchase of 100,000 Ordinary Shares on 11/10/2025 at a weighted average price of $3.45, with trade prices ranging from $3.44 to $3.50.

Following the transaction, the reporting person beneficially owns 1,100,000 shares indirectly through Cornick Family Investor, LLC and 32,711 shares directly. Cornick Family Investor, LLC is controlled by Mr. Cornick and his spouse.

Clarivate Plc filed a shelf registration on Form S-3 that includes the potential primary offering of various securities and the resale, from time to time, of up to 245,076,317 ordinary shares by certain selling shareholders. These holders received shares in prior transactions, including the ProQuest (December 2021), CPA Global (October 2020), Decision Resources Group (February 2020) deals, and the 2019 merger with Churchill Capital Corp.

The company may offer ordinary shares, preferred shares, debt securities, warrants, purchase contracts, and units via future supplements. Clarivate will not receive proceeds from selling shareholder resales; proceeds from any primary issuances would be for general corporate purposes. Ordinary shares are listed on NYSE as “CLVT,” last reported at $3.54 on November 3, 2025. As context, 661,435,069 ordinary shares were outstanding as of September 30, 2025. Investors are directed to risk factors incorporated by reference from the 2024 Form 10-K and subsequent filings.

Clarivate plc (CLVT) insider activity: A director reported open‑market purchases of Ordinary Shares through Cornick Family Investor, LLC. On 10/31/2025, the entity bought 500,000 shares at a weighted average price of $3.38 (prices ranged from $3.34 to $3.40). On 11/03/2025, it bought 225,000 shares at a weighted average price of $3.52 (range $3.37 to $3.55).

Following these trades, 1,000,000 shares were beneficially owned indirectly via Cornick Family Investor, LLC, and 32,711 shares were held directly. The filing notes the LLC is controlled by Mr. Cornick and his spouse, who have voting and dispositive control over its shares.

Clarivate plc (CLVT): Director transaction disclosed. Andrew M. Snyder reported purchasing 1,460,000 ordinary shares on 10/31/2025 at a weighted average price of $3.33. The filing notes the trade prices ranged from $3.25 to $3.40, with full breakdowns available upon request.

Following the transaction, Snyder reported beneficial ownership across multiple accounts: 2,247,510 shares indirectly through Cambridge Information Group I LLC; 177,451 shares held directly; 10,489,466 shares indirectly through Cambridge Information Group II LLC; 4,033,271 shares indirectly through Cambridge Information Group III LLC; 8,821,984 shares indirectly through Cambridge Information Group Inc.; 3,417 shares indirectly through CSA GP Corporation; and 238,500 shares indirectly through the Snyder 2011 Family Trust. He disclaims beneficial ownership except to the extent of his pecuniary interest.

Clarivate (CLVT) reported Q3 2025 results with revenue of $623.1 million, essentially flat year over year. Income from operations improved to $44.0 million from $21.7 million as cost controls offset higher depreciation and amortization. Net loss narrowed to $28.3 million from $65.6 million, and interest expense declined to $68.5 million from $72.2 million.

Year to date, revenue was $1,838.2 million versus $1,893.7 million, reflecting divestitures and product wind-downs. Segment Adjusted EBITDA totaled $252.4 million in the quarter. Operating cash flow reached $468.6 million for the nine months, supporting capital expenditures of $192.5 million and share repurchases of $149.5 million for approximately 34.8 million shares. Long-term debt was $4,419.0 million, down from $4,518.7 million, aided by redeeming $600.0 million of 2026 senior secured notes and adding a $500.0 million Tranche 2 term loan. Ordinary shares outstanding were 661,435,069 as of September 30, 2025.

Clarivate Plc furnished an update on operations by releasing its earnings press release for the third quarter ended September 30, 2025. The company made the press release available as Exhibit 99.1 and posted it on its investor relations website.

The company also furnished supplemental materials covering revenue, earnings, and guidance as Exhibit 99.2, likewise posted on its investor relations site. The materials in Items 2.02 and 7.01 are being furnished and are not deemed filed under the Exchange Act.

Andrew M. Snyder, a director of Clarivate Plc (CLVT), reported stock award and withholding transactions dated 09/30/2025. He received 13,381 ordinary shares as a quarterly election in lieu of a $51,250 cash retainer, calculated at the closing price of $3.83 per share. 419 shares were withheld to satisfy taxes, leaving Mr. Snyder with 177,870 shares directly beneficially owned after the award. The filing also discloses large indirect holdings through related entities, including 8,821,984, 787,510, 10,489,466, and 4,033,271 ordinary shares held by Cambridge Information Group affiliates, and 238,500 shares held by the Snyder 2011 Family Trust.